Cargando…
Lung microbiome and host immune tone in subjects with idiopathic pulmonary fibrosis treated with inhaled interferon-γ
Therapies targeting inflammation reveal inconsistent results in idiopathic pulmonary fibrosis (IPF). Aerosolised interferon (IFN)-γ has been proposed as a novel therapy. Changes in the host airway microbiome are associated with the inflammatory milieu and may be associated with disease progression....
Autores principales: | Wang, Jing, Lesko, Melissa, Badri, Michelle H., Kapoor, Bianca C., Wu, Benjamin G., Li, Yonghua, Smaldone, Gerald C., Bonneau, Richard, Kurtz, Zachary D., Condos, Rany, Segal, Leopoldo N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5507144/ https://www.ncbi.nlm.nih.gov/pubmed/28717640 http://dx.doi.org/10.1183/23120541.00008-2017 |
Ejemplares similares
-
Immunomodulation with Recombinant Interferon-γ1b in Pulmonary Tuberculosis
por: Dawson, Rod, et al.
Publicado: (2009) -
Interferon-γ enhances the antifibrotic effects of pirfenidone by attenuating IPF lung fibroblast activation and differentiation
por: Vu, Tuong N., et al.
Publicado: (2019) -
Exogenous Interferon-α and Interferon-γ Increase Lethality of Murine Inhalational Anthrax
por: Gold, Jeffrey A., et al.
Publicado: (2007) -
Shrinkage improves estimation of microbial associations under different normalization methods
por: Badri, Michelle, et al.
Publicado: (2020) -
The Unfulfilled Promise of Inhaled Therapy in Ventilator-Associated Infections: Where Do We Go from Here?
por: Palmer, Lucy B., et al.
Publicado: (2022)